YZY Medical

Home
China
Wuhan
YZY Medical

Molecular Diagnosis，FISH Comprehensive Solution，Pharmacogenomics ,Tumor Targeted Companion Detection

01/08/2025

Our technical team conducted HER-2 FISH experiments and hands-on training at an oncology hospital. The results have gained clinical recognition, marking a productive collaboration.

24/06/2025

Our tech team successfully completed the pre-clinical trial of MYC/BCL2/BCL6 FISH probes for lymphoma diagnosis at a hospital in Northwest China, with results earning clinical recognition. A step forward in precision medicine! 🧬 "

MYC/BCL2/BCL6 FISH probes are vital for detecting genetic aberrations in lymphomas, aiding in diagnosis, prognosis, and tailored therapy. 🧬

12/05/2025

To the extraordinary nurses around the globe, your tireless efforts, gentle hands, and compassionate hearts light up the darkest days—happy International Nurses Day!

09/05/2025

The CTCBIOPSY circulating tumor cell detection system A10 was successfully installed in a large hospital in central - southern China! Our tech team were conducting thorough training on detection operation and slides reading. The initial experimental results were highly recognized. 🎉

29/04/2025

How does Separator work?
What are the key features of the CTC Separator?...
For more product information, we sincerely welcome you to contact us to book a video chat. Email:info@yzymedical.com

25/04/2025

Adhering to the mission of "tailored treatment for people", YZY MED has launched a new tumor methylation detection product, human gene methylation detection kit (PCR-fluorescence probe method), which has officially obtained the registration certificate of Class III Medical Devices of the State Food and Drug Administration (National Registration No.20253400796). With non-invasive, accurate and convenient gene detection technology, Open a new chapter of cancer early screening.

16/04/2025

On April 8, 2025, the 91st China International Medical Equipment Fair (CMEF) was successfully concluded in Shanghai National Convention and Exhibition Center. YZY MED showcased numerous scientific and technological achievements to global customers, which attracted the attention of the audience, industry peers and international clients.

As a leading innovator in the field of molecular diagnosis, pathology and precision medicine in China, YZY MED has made a major debut with integrated CTC isolation and staining machine, FISH probe and related equipment. YZY MED focuses on individualized diagnosis and treatment of major diseases such as cardiovascular disease and tumor. The booth drew the attention of distributors and business partners from various countries, with a steady influx of both established and prospective customers engaging in business negotiations.

The D200 all-in-one circulating tumor cell separation and staining system showcased at this exhibition has drawn considerable attention as a leading solution for real-time cancer monitoring in the field of liquid biopsy. This innovative device employs a marker-independent cell separation technology capable of processing individual samples in less than 10 minutes. It enables precise CTC (Circulating Tumor Cell) subtyping and accurate CTM (Circulating Tumor Microemboli) classification, particularly effective in identifying high-risk metastatic patients with neutrophil-rich CTMs.

Meanwhile, the company has showcased its advanced FISH probe reagents and the fully automated FISH slide processing system F902, which demonstrate outstanding performance in fluorescence in situ hybridization applications. As a non-invasive molecular cytogenetic technique, FISH technology allows direct detection of specific nucleic acid sequences within cells and is widely applied in cancer diagnosis, treatment efficacy monitoring, and prognostic evaluation.

While the exhibition has concluded, the pace of technological innovation at YZY MED will never cease. We look forward to continuing our collaboration with global partners, leveraging technology as our vessel and cooperation as our oar, to jointly address industry challenges and propel healthcare into a new era characterized by greater efficiency, accessibility, and intelligence.

09/04/2025

Day 1 at 2025 CMEF Shanghai! 🎉 Dive into the future of healthcare with YZY Medical at booth 7.1E05. From advanced pathology diagnostics to precision cancer screening and personalized medication solutions, we're redefining medical innovation. Don't miss the chance to experience our cutting-edge technologies and explore custom solutions tailored to your needs.

03/04/2025

We’re delighted to welcome our Indian clients in March. Our esteemed guest, a leading figure in the Indian medical diagnostic field, was thoroughly impressed with the advanced technology and high efficiency of YZY’ s FISH production line. During the visit, the client lauded the remarkable adaptability of our FISH products, highlighting their compatibility with various diagnostic systems.
The client also emphasized that our products’ unique feature of remaining stable at normal temperatures significantly reduces the complexity and cost of international logistics. In addition, both parties held in - depth discussions on a comprehensive cooperation plan, covering the introduction of FISH products to the Indian market and the establishment of long - term technical support mechanisms.
The molecular diagnostics market in India is burgeoning. According to the research report, India’s IVD market is set to experience substantial growth in the foreseeable future. The expansion of the healthcare system, increasing awareness of early disease detection, and the government’s proactive initiatives in promoting healthcare innovation are fueling this growth.
sincerely looks forward to more exchanges with overseas clients. We are committed to providing high - quality diagnostic solutions, contributing to improving the lives of cancer and tumor patients globally.

26/03/2025

The 22nd China International Laboratory Medicine & Transfusion Instruments and Reagents Expo ( 2025) concluded successfully on March 24th at the Hangzhou Grand Convention & Exhibition Center, bringing together 1,300+ exhibitors from 23 countries and 100,000+ professionals under the theme of innovation and global healthcare advancement.
At CACLP 2025，YZY MED showcased cutting-edge IVD solutions, including the F902 FISH automated system—a fully open platform enabling multi-probe processing for diverse samples—and the D200 CTC separation and staining system, achieving end-to-end automation with 50-minute processing for six samples. Highlighting advancements in oncology and cardiovascular diagnostics, YZY MED reinforced its leadership in precision medicine through innovative automation, compatibility, and efficiency. The event amplified the brand’s global recognition, particularly in CTC detection technology. As YZY MED continues advancing clinical diagnostics, we eagerly anticipate future collaborations at the next CACLP!

18/03/2025

Product managers conduct recent clinical visits for the CDx project, sharing its applications.

12/03/2025

Installation Site of YZYMED'S Cell Separation and Staining System D200: Where Precision Meets Performance
D200, a circulating tumor cell separation and staining system, was installed in a hospital in northwest China. Its excellent cell isolation and staining results got high praise from clinicians 🎉 .
It can automatically isolate and stain circulating tumor cells in 5ml blood samples, handle 6 samples simultaneously, and significantly shorten the sample testing time.

Address

388 Gaoxin 2nd Road, Optics Valley, East Lake Hi-Tech Development Zone
Wuhan
430075

Website

https://www.yzymed.cn/

Alerts

Be the first to know and let us send you an email when YZY Medical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Wuhan?